Nicolai E, Cuocolo A, Pace L, Nappi A, Sullo P, Cardei S, Argenziano L, Squame F, Ell P J, Salvatore M
Cattedra di Medicina Nucleare, Centro per la Medicina Nucleare del CNR, Università Federico II, Napoli, Italy.
J Nucl Cardiol. 1996 Jan-Feb;3(1):9-17. doi: 10.1016/s1071-3581(96)90019-7.
Exercise and dipyridamole 99mTc-labeled methoxy isobutyl isonitrile (MIBI) myocardial scintigraphy have been widely used for the diagnosis of coronary artery disease (CAD). However, only limited data on adenosine 99mTc-labeled MIBI cardiac imaging are currently available. This study was designed to assess the accuracy of quantitative adenosine-rest 99mTc-labeled MIBI tomography in the diagnosis and localization of CAD.
Fifty-seven consecutive patients with suspected CAD who underwent coronary angiography and 22 normal volunteers were studied. All patients underwent 99mTc-labeled MIBI tomography after administration of adenosine (140 micrograms/kg intravenously for 6 minutes) and at rest. A total of 171 vascular coronary territories were analyzed quantitatively. All patients with CAD (> or = 50% luminal stenosis) (n = 55) had abnormal 99mTc-labeled MIBI tomograms. The normalcy rate was 86% by quantitative analysis. Overall sensitivity, specificity, and diagnostic accuracy for detection of individual stenosed vessels were 84%, 87%, and 85%, respectively. In patients with one-vessel CAD (n = 24), sensitivity and diagnostic accuracy in the detection of individual stenosed vessels were significantly (p < 0.05) higher compared with patients with multivessel CAD (n = 31). Moreover, 75% of patients with one-vessel disease showed a scintigraphic pattern characterized by the presence of perfusion defects in only one coronary artery territory, and 74% of patients with multivessel disease showed a scintigraphic pattern characterized by the presence of perfusion defects in two or more coronary artery territories. Sensitivity, specificity, and diagnostic accuracy for detecting individual diseased vessels were similar in patients without previous myocardial infarction (n = 18) compared with those with previous myocardial infarction (n = 39). In myocardial territories related to noninfarcted areas (n = 124), sensitivity and specificity in the detection of stenosed vessels were 75% and 88%. In infarcted areas (n = 47), sensitivity and specificity in the detection of stenosed vessels were 98% and 80% (differences not significant vs noninfarcted areas).
Adenosine-controlled coronary vasodilation combined with quantitative 99mTc-labeled MIBI tomography is accurate for identifying patients with CAD and localizing individual stenosed coronary arteries.
运动及双嘧达莫负荷99m锝-甲氧基异丁基异腈(MIBI)心肌闪烁扫描术已广泛用于冠状动脉疾病(CAD)的诊断。然而,目前关于腺苷负荷99m锝-MIBI心肌显像的数据有限。本研究旨在评估腺苷负荷静息99m锝-MIBI断层扫描在CAD诊断及定位中的准确性。
对57例连续的疑似CAD患者进行冠状动脉造影检查,并纳入22名正常志愿者作为研究对象。所有患者在静脉注射腺苷(140微克/千克,持续6分钟)后及静息状态下均接受99m锝-MIBI断层扫描。共对171个冠状动脉节段进行了定量分析。所有CAD患者(管腔狭窄≥50%)(n = 55)的99m锝-MIBI断层扫描均异常。定量分析的正常率为86%。检测单个狭窄血管的总体敏感性、特异性及诊断准确性分别为84%、87%和85%。在单支血管CAD患者(n = 24)中,检测单个狭窄血管的敏感性及诊断准确性显著高于多支血管CAD患者(n = 31)(p < 0.05)。此外,75%的单支血管病变患者的闪烁扫描图像表现为仅一个冠状动脉节段存在灌注缺损,74%的多支血管病变患者的闪烁扫描图像表现为两个或更多冠状动脉节段存在灌注缺损。与有既往心肌梗死的患者(n = 39)相比,无既往心肌梗死的患者(n = 18)检测单个病变血管的敏感性、特异性及诊断准确性相似。在与非梗死区域相关的心肌节段(n = 124)中,检测狭窄血管的敏感性及特异性分别为75%和88%。在梗死区域(n = 47)中,检测狭窄血管的敏感性及特异性分别为98%和80%(与非梗死区域相比差异无统计学意义)。
腺苷控制的冠状动脉血管扩张联合定量99m锝-MIBI断层扫描在识别CAD患者及定位单个狭窄冠状动脉方面具有准确性。